ArticleJournal of applied clinical medical physics2025
Markerless tumor tracking for lung SBRT with the Radixact Synchrony system: Initial experience and short-term clinical outcomes.
Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Dosimetric impact of daily MR-guided adaptive radiotherapy across different anatomical sites.Irish journal of medical science · 2026Article
- Markerless tumor tracking for lung SBRT with the Radixact Synchrony system: Initial experience and short-term clinical outcomes.Journal of applied clinical medical physics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo report the initial clinical experience with the radixact synchrony lung with respiratory (LWR) technique in stereotactic body radiotherapy (SBRT) for lung tumors, focusing on feasibility, dosimetric performance, and early clinical outcomes using both standard and extended fractionation regimens.
methodsTwenty patients with primary or metastatic lung tumors were treated using the Synchrony LWR technique. Patients were selected based on respiratory stability and favorable imaging characteristics. All patients underwent a Synchrony simulation, which included tumor tracking volume (TTV) definition and kV radiograph acquisition to assess their suitability for treatment with this technique. Treatment plans were generated using Precision TPS with VoloUltra. Plan verification, including gamma analysis and point dose measurements, was performed using the PTW Octavius system and dynamic motion QA. Synchrony model parameters, treatment times, and intrafraction interruptions were analyzed. Clinical follow-up included imaging and toxicity assessment.
resultsTreatment was successfully delivered in all patients with median beam-on and treatment durations of 9.1 and 14.5 min, respectively. The median number of intrafraction interruptions was 1.95, and none of the fractions were canceled due to prolonged delivery. The mean kV imaging dose per fraction was 0.90 cGy. Dosimetric QA under motion showed gamma passing rates >93% and < 2% deviation in point dose. At a median follow-up of 9 months, the local control rate was 100%, with no grade ≥2 toxicities observed.
conclusionsThe Radixact Synchrony LWR technique enables efficient and non-invasive respiratory motion management in lung SBRT. This early experience demonstrates its feasibility with clinically acceptable delivery accuracy and promising short-term clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.